LIFE - aTyr Pharma, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
0.8998
-0.0120 (-1.32%)
As of 10:17AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.9118
Open0.9000
Bid0.8901 x 1800
Ask0.8950 x 1400
Day's Range0.8900 - 0.9000
52 Week Range0.8000 - 6.4960
Volume177,595
Avg. Volume869,855
Market Cap26.84M
Beta3.18
PE Ratio (TTM)N/A
EPS (TTM)-1.6650
Earnings DateAug 13, 2018 - Aug 17, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.00
Trade prices are not sourced from all markets
  • GlobeNewswire21 days ago

    aTyr Pharma Announces Positive Phase 1 Data for ATYR1923 Therapeutic Candidate

    SAN DIEGO, June 26, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced positive data from its Phase 1 clinical trial of ATYR1923, an immuno-modulatory therapeutic candidate with potentially broad therapeutic application in the treatment of interstitial lung diseases. This first-in-human, randomized, double-blind, placebo-controlled study was designed to investigate the safety, tolerability, immunogenicity and pharmacokinetics of intravenous ATYR1923 in healthy volunteers.  The Phase 1 study enrolled 36 healthy volunteers who were randomized to one of six cohorts and received a single infusion of intravenous ATYR1923 or placebo.

  • Thomson Reuters StreetEventslast month

    Edited Transcript of LIFE earnings conference call or presentation 19-Mar-18 9:00pm GMT

    Q4 2017 aTyr Pharma Inc Earnings Call

  • GlobeNewswire2 months ago

    aTyr Pharma to Present at Jefferies 2018 Global Healthcare Conference

    SAN DIEGO, May 31, 2018-- aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced that Sanjay ...

  • GlobeNewswire2 months ago

    aTyr Pharma Presents Poster on Preclinical Data from ATYR1923 Program at American Thoracic Society 2018 International Conference

    SAN DIEGO, May 17, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced a poster presentation at the American Thoracic Society (ATS) International Conference to be held from May 18 – 23, 2018 in San Diego, CA. The presentation discusses the preclinical characterization of ATYR1923 as an immuno-modulatory therapeutic candidate with potentially broad therapeutic application in interstitial lung diseases. “We are excited to present a thorough summary of our preclinical work from our ATYR1923 program, specifically as it relates to potential activity in interstitial lung diseases at the ATS International Conference in San Diego next week,” commented David King, Ph.D., Chief Scientific Officer of aTyr.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of LIFE earnings conference call or presentation 14-May-18 12:00pm GMT

    Q1 2018 aTyr Pharma Inc Earnings Call

  • Associated Press2 months ago

    Atyr Pharma: 1Q Earnings Snapshot

    On a per-share basis, the San Diego-based company said it had a loss of 36 cents. The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...

  • GlobeNewswire2 months ago

    aTyr Pharma Announces First Quarter 2018 Operating Results, Program Prioritization and Corporate Restructuring

    SAN DIEGO, May 14, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced operating results for the first quarter ended March 31, 2018. In light of this, the Company has implemented a corporate restructuring based on the resources necessary to continue to develop ATYR1923 and pursue additional research efforts for the ORCA program.

  • ACCESSWIRE2 months ago

    aTyr Pharma, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / May 14, 2018 / aTyr Pharma, Inc. (NASDAQ: LIFE ) will be discussing their earnings results in their Q1 Earnings Call to be held on May 14, 2018 at 8:00 AM Eastern Time. To listen ...

  • GlobeNewswire2 months ago

    aTyr Pharma to Host Conference Call and Webcast of First Quarter 2018 Financial Results on May 14, 2018

    SAN DIEGO, May 08, 2018-- aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced that it will ...

  • GlobeNewswire2 months ago

    aTyr Pharma Provides Mechanistic Update on Resokine Pathway at American Academy of Immunology Annual Meeting

    SAN DIEGO, May 02, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced a poster presentation at the American Academy of Immunology (AAI) Annual Meeting in Austin, Texas from May 4 - 8, 2018. The presentation discusses the identification of a T cell immunomodulatory domain in histidyl-tRNA synthetase (HARS). David King, Ph.D., aTyr’s Chief Scientific Officer commented, “The preclinical data presented in this poster highlights a very important understanding of extracellular proteins derived from HARS, which we refer to as Resokine.

  • aTyr Pharma, Inc. (LIFE) Sees Hammer Chart Pattern: Time to Buy?
    Zacks4 months ago

    aTyr Pharma, Inc. (LIFE) Sees Hammer Chart Pattern: Time to Buy?

    aTyr Pharma, Inc. (LIFE) Sees Hammer Chart Pattern: Time to Buy?

  • Associated Press4 months ago

    Atyr Pharma reports 4Q loss

    The San Diego-based company said it had a loss of 39 cents per share. The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a ...

  • ACCESSWIRE4 months ago

    aTyr Pharma, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / March 19, 2018 / aTyr Pharma, Inc. (NASDAQ: LIFE ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 19, 2018, at 5:00 PM Eastern Time. ...

  • Associated Press8 months ago

    Atyr Pharma reports 3Q loss

    The San Diego-based company said it had a loss of 43 cents per share. The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for ...

  • Zacks.com featured highlights include article Kraton, aTyr Pharma, Grupo Financiero Galicia, Grupo Supervielle and Calithera Biosciences
    Zacks9 months ago

    Zacks.com featured highlights include article Kraton, aTyr Pharma, Grupo Financiero Galicia, Grupo Supervielle and Calithera Biosciences

    Zacks.com featured highlights include article Kraton, aTyr Pharma, Grupo Financiero Galicia, Grupo Supervielle and Calithera Biosciences